Why Molecular Diagnostics?
Infectious diseases are becoming increasingly more difficult to manage.
Molecular biology tools bring a high level of sensitivity and specificity to diagnostics. These tools can detect bacteria, viruses, parasites, yeasts, or genetic markers through the presence of DNA or RNA genetic sequences in clinical samples. Tests are performed directly on a clinical sample and make it possible to obtain results in as little as ~15 minutes.
In addition to detecting pathogens, molecular tests can identify antimicrobial genes and can allow for viral quantification in patient's samples. These results help clinicians make decisions regarding treatment and monitor the effectiveness of treatment.
Molecular diagnostics have revolutionized the field of medical testing by allowing for earlier and more accurate diagnosis, personalized treatment plans, and improved patient outcomes.
These tests are being used more and more to guide patient management. From diagnosis to treatment, particularly in infectious diseases, clinicians need molecular tools that are reliable, fast, and easy to use.
What challenges are infectious disease labs facing today?
Healthcare professionals often experience slow, incomplete, and unreliable tests to identify pathogens of infectious diseases and accompanying antimicrobial resistance genes, resulting in suboptimal patient treatment and management.
The accessibility to a complete diagnosis, especially on molecular assays, has never been so easy but infectious disease labs still have high expectations:
- Same-day Results: expectation for fast turnaround times; testing is expected to be completed the same day specimen is received
- Flexibility: ability to manage a variety of different samples and manage different contexts: routine testing, research topics, clinical trials, and more
- Accuracy: reduce the incidence of under-quantification, false negative or positive results
- Safety Concerns: minimize all cross-contamination risk especially during the pipetting steps and ensure operator safety
It’s imperative that labs have the products and solutions that guarantee the highest levels of reliability, rapidity, and safety. Molecular technologies offer an effective solution for infectious disease diagnostics because they are agile, fast, reliable, and precise.
How can our Molecular Diagnostic Solutions help?
Molecular diagnostic solutions from bioMérieux play a crucial role in identifying and detecting various infectious diseases. Our offer includes flexible molecular systems and integrated multiplex PCR systems with a broad menu of high-quality in vitro diagnostics, plus expert support. We help healthcare professionals quickly and accurately diagnose infections, monitor disease progression, and guide appropriate treatment decisions. Our goal is to not only help labs succeed in addressing current and future disease management, but also enable the scalability to react in an outbreak situation.
Our solutions confidently meet the challenges faced by labs by offering same-day reliable results with flexible workflows and systems designed to reduce safety risk. The routine use of our molecular diagnostic solutions will help decrease healthcare resources, increase efficiency, and allow rapid responses to new threats.
Our Molecular Diagnostic Offer
Testing early with molecular diagnostic solutions from bioMérieux has demonstrated improved patient outcomes, optimized patient management, better antimicrobial stewardship, and cumulative cost and time-savings realized throughout the entire patient pathway.
Disclaimer: Product availability varies by country. Please consult your local bioMérieux representative for product availability in your country.
Leading the Industry in Syndromic PCR Testing for Infectious Diseases
Our automated, user-friendly platforms require just two minutes of hands-on time, optimizing laboratory productivity with automated, around-the-clock diagnostic testing. Features include scalable design, simplified workflow, and LIS-interfacing capabilities. Our panel portfolio includes six syndromic panels providing pathogen-specific results in about an hour. With over 170 targets, the BIOFIRE® FILMARRAY® Panel portfolio offers the largest infectious disease menu on the market.
-
BIOFIRE® FILMARRAY® TORCH
Easier testing. Faster results.
Syndromic infectious disease testing with BIOFIRE® FILMARRAY® TORCH is the fastest way to better results.
-
BIOFIRE® Respiratory 2.1 and 2.1plus Panels
1 Test. Up to 23 Targets. ~45 Minutes.
The BIOFIRE RP2.1 and RP2.1plus Panels use the syndromic approach to accurately detect and identify the pathogens most associated with respiratory infections. Fast and comprehensive results may enable better-informed diagnosis and treatment of patients.
-
BIOFIRE® Blood Culture Identification 2 Panel
1 Test. 43 Targets. ~1 Hour.
The BIOFIRE BCID2 Panel tests for 43 targets associated with bloodstream infections, including Gram-negative bacteria, Gram-positive bacteria, yeast, and 10 antimicrobial resistance genes – all with one test and with results available in about an hour from positive blood culture.
-
BIOFIRE® FILMARRAY® Gastrointestinal (GI) Panels
1 Test. 11 or 22 Targets. ~1 Hour
BIOFIRE FILMARRAY GI Panels are fast and sensitive molecular stool testing methods for infectious gastrointestinal disease.
BIOFIRE® FILMARRAY® Gastrointestinal (GI) Panel tests for 22 targets from one patient sample. Its comprehensive menu includes 13 bacteria, 5 viruses and 4 parasites commonly associated with infectious gastroenteritis.
BIOFIRE® FILMARRAY® Gastrointestinal (GI) Panel Mid tests for 11 targets and offers clinicians another GI testing option. Its menu includes 7 bacteria, 1 virus and 3 parasites associated with infectious gastroenteritis. -
BIOFIRE® FILMARRAY® Meningitis/Encephalitis Panel
1 Test. 14 Targets. ~1 Hour.
The BIOFIRE ME Panel provides answers on 14 of the most common bacterial, viral, and yeast pathogens that cause central nervous system infections to help healthcare providers rapidly distinguish between bacterial and viral meningitis and optimize life-saving therapy.
-
BIOFIRE® FILMARRAY® Pneumonia & Pneumonia plus Panels
1 Test. Up to 34 Targets. ~1 Hour.
Syndromic tests targeting a comprehensive menu of bacteria and viruses that cause pneumonia and other lower respiratory tract infections, as well as 7 genetic markers of antibiotic resistance.
-
BIOFIRE® Joint Infection Panel
1 Test. 39 Targets. ~1 Hour.
Using PCR technology, the BIOFIRE JI Panel is a rapid syndromic test that delivers comprehensive results in one easy-to-read report.
Our latest advancement in syndromic infectious disease diagnostics, the BIOFIRE® SPOTFIRE® System is specifically designed for point-of-care testing. All our expertise and cutting-edge FILMARRAY® technology is at the heart of the system's design. Our revolutionary portfolio of versatile, respiratory PCR tests give clinicians targeted and syndromic options as they care for a variety of patients.
-
BIOFIRE® SPOTFIRE® System
This Changes Everything.
The BIOFIRE® SPOTFIRE® System is the latest advancement in molecular infectious disease diagnostics from bioMérieux for Point-of-Care testing, offering rapid and actionable results onsite.
-
BIOFIRE® SPOTFIRE® Respiratory/Sore Throat Panels
Comprehensive Onsite PCR Results in ~15 Minutes.
The BIOFIRE SPOTFIRE Respiratory/Sore Throat (R/ST) Panels enable testing for respiratory pathogens from either a nasopharyngeal swab or a throat swab, providing a flexible respiratory solution to meet the unique needs of point-of-care settings.
-
EMAG®
Nucleic Acid Extraction System
EMAG® offers efficient and flexible extraction to manage both routine and challenging customer needs, supported by a committed and skilled team at bioMérieux.
-
ARGENE® Respiratory
R-GENE® Respiratory PCR kits
ARGENE® Respiratory includes ready-to-use real-time PCR detection kits for viral respiratory diseases.
